Frankfurt, Germany - Soluble CD40 ligand can be used to identify ACS patients at highest risk for cardiac events and those who will receive most benefit from the GP IIb/IIIa blocker abciximab, a new ...
The 2025 American Heart Association/American College of Cardiology Guidelines on the management of acute coronary syndromes (ACS) were finally published recently, marking the first update after an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback